August 29, 2026
PEHA’s Net Profit Surges 511% in the First Half of 2026
PT Phapros Tbk (PEHA), part of the State-Owned Pharmaceutical Holding and Danantara Indonesia, continued to record positive financial performance growth in the first half of 2026...
See More
August 06, 2026
Phapros Supports Bakti Indonesia at Sam Poo Kong, Providing Community Health Services and Strengthening Diversity
Phapros is supporting the Bakti Indonesia: Social Charity Movement in Indonesia’s Diversity initiative organized by the Yayasan Bakti Keberagaman Indonesia (YBKI)...
See More
July 10, 2026
Commission VI of the DPR RI Reviews Phapros, Encourages the Strengthening of National Pharmaceutical Industry Independence
Phapros received a Specific Working Visit from Commission VI of the House of Representatives of the Republic of Indonesia (DPR RI) at the Simongan Factory, Semarang, on Friday (10/7). ...
See More
June 21, 2026
Celebrating a 72-Year Journey, Phapros Conducts Various Real Actions for the Community & Environment
SEMARANG, June 21, 2026 – PT Phapros Tbk ("PEHA"), a leading pharmaceutical company in Indonesia, has been on a 72-year journey (June 21, 1954 – June 21, 2026) contributing to Indonesia's health. The peak of the celebration series, themed "Phapros is Healthy, Healthy is Phapros," was held at the Phapros Simongan Factory, Semarang on Sunday, June 21, 2026...
See More
June 11, 2026
Successfully Printing 109% Profit Growth in 2025, Phapros (PEHA) Distributes 15% Dividend
PT Phapros Tbk ("PEHA"), a leading pharmaceutical company in Indonesia, has successfully held its Annual General Meeting of Shareholders (AGMS) in Jakarta, Thursday, June 11, 2026....
See More
June 11, 2026
Executing 5 Strategic Steps, Phapros (PEHA) is Optimistic to Continue the Positive Trend of Sales & Net Profit Growth Throughout 2026
PT Phapros Tbk ("PEHA"), a leading pharmaceutical company in Indonesia, is optimistic about continuing the positive trend of its financial performance in 2026. ...
See More